Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients (18 years or older) with clear epidemiological history; fever and/or respiratory symptoms; normal or decreased white blood cell (WBC) count and/or lymphocyte count; high degree of suspected imaging characteristics of novel coronavirus pneumonia; positive results of SARS-CoV-2 nucleic acid detection and serum-specific antibodies; ability to provide a signed informed consent form.
Exclusion criteria
Exclusion criteria: Patients were excluded if known life expectancy was less than 48 h, pregnant or lactating, diagnosed with end-stage diseases, or in immunosuppression states.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change in the clinical classification of COVID-19 patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| the proportion of patients with different disease severity types;critical deterioration events of patients during treatment, including total incidences and classification of each type of event;patients with unplanned transfers to ICU and requiring critical care interventions;time intervals from patient warning information received to implementation of clinical interventions;hospital mortality;length of ICU stay;length of hospital stay;workload of physicians and nurses during study period;risks of exposure to potential COVID-19 patients; | — |
Countries
China
Contacts
Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China